A GHRP-6/Mod GRF(1-29) blend combines a growth hormone releasing peptide with a growth hormone releasing hormone analogue. GHRP-6 stimulates ghrelin receptors while Mod GRF amplifies the GH pulse, producing a synergistic effect.

Research protocols commonly use 100-200 mcg of each component, administered subcutaneously 2-3 times daily. Dosing is often timed around sleep and fasted states to maximize GH pulse amplitude.

Yes, GHRP-6 is known for stimulating strong appetite increases due to its action on ghrelin receptors. This is a significant difference from Ipamorelin, which has minimal appetite effects. Factor this into protocol planning.